JACKSONVILLE BEACH, Fla., January 14, 2025--(BUSINESS WIRE)--Dubin Clark is thrilled to announce two major milestones: receiving its first Small Business Investment Company (SBIC) license and ...

Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

Biohacker Bryan Johnson (front), 47, and his son, Talmage, 19, are featured in the new Netflix documentary "Don't Die: The Man Who Wants to Live Forever." Bryan Johnson / Instagram What a father ...

What the government refers to as “Anomalous Health Incidents,” Havana syndrome has afflicted hundreds ... that Turner was removed as a result of Johnson’s deference to President-elect ...

House Speaker Mike Johnson (R-La.) said Friday abortion opponents are “entering a new era” with President Trump and Vice President Vance in the White House. Speaking at the March for Life ...

Anti-aging advocate Bryan Johnson, who gulps down 54 pills for breakfast, recently discovered a wrinkle in his meticulous approach to dodging death. Every two weeks, the 47-year-old tech ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Stevens-Johnson syndrome (SJS), also called erythema multiforme major, is a systemic disease mostly involving the skin and mucous membranes. The cutaneous lesions are those of erythema multiforme ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...